Cost-Effectiveness Analysis and Stakeholder Evaluation of 2 Obesity Prevention Policies in Maine, US

被引:21
|
作者
Long, Michael W. [1 ]
Polacsek, Michele [2 ]
Bruno, Pamela [2 ]
Giles, Catherine M. [3 ]
Ward, Zachary J. [4 ]
Cradock, Angie L. [3 ]
Gortmaker, Steven L. [3 ]
机构
[1] George Washington Univ, Milken Inst, Sch Publ Hlth, Dept Prevent & Community Hlth, 950 New Hampshire Ave NW,3rd Floor, Washington, DC 20052 USA
[2] Univ New England, Dept Publ Hlth, Coll Hlth Profess, Portland, ME USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA
[4] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA
关键词
nutrition policy; stakeholder engagement; cost effectiveness; SUGAR-SWEETENED BEVERAGES; NUTRITION ASSISTANCE PROGRAM; CHILDHOOD OBESITY; PUBLIC-HEALTH; WEIGHT-GAIN; BODY-WEIGHT; EXCISE TAX; IMPACT; FOOD; SUBSIDIES;
D O I
10.1016/j.jneb.2019.07.005
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objective: To evaluate the potential cost-effectiveness of and stakeholder perspectives on a sugar-sweetened beverage (SSB) excise tax and a Supplemental Nutrition Assistance Program (SNAP) policy that would not allow SSB purchases in Maine, US. Design: A cost-effectiveness simulation model combined with stakeholder interviews. Setting: Maine, US. Participants: Microsimulation of the Maine population in 2015 and interviews with stakeholders (n = 14). Study conducted from 2013 to 2017. Main Outcome Measures: Health care cost savings, net costs, and quality-adjusted life-years (QALYs) from 2017 to 2027. Stakeholder positions on policies. Retail SSB cost and implementation cost data were collected. Analysis: Childhood Obesity Intervention Cost-Effectiveness Study project microsimulation model with uncertainty analysis to estimate cost-effectiveness. Thematic stakeholder interview coding. Results: Over 10 years, the SSB and SNAP policies were projected to reduce health care costs by $78.3 million (95% uncertainty interval [UI], $31.7 million-$ 185 million) and $15.3 million (95% UI, $8.32 million-$23.9 million), respectively. The SSB and SNAP policies were projected to save 3,560 QALYs (95% UI, 1,447-8,361) and 749 QALYs (95% UI, 415-1,168), respectively. Stakeholders were more supportive of SSB taxes than the SNAP policy because of equity concerns associated with the SNAP policy. Conclusions and Implications: Cost-effectiveness analysis provided evidence of potential health improvement and cost savings to state-level stakeholders weighing broader implementation considerations.
引用
收藏
页码:1177 / 1187
页数:11
相关论文
共 50 条
  • [41] Exercise for the Prevention of Preterm Birth: A Cost-Effectiveness Analysis
    Speranza, Rosa
    Sargent, James
    Savitsky, Leah
    Caughey, Aaron B.
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 51S - 51S
  • [42] COST-EFFECTIVENESS ANALYSIS OF HEPATITIS-A PREVENTION IN TRAVELERS
    TORMANS, G
    VANDAMME, P
    VANDOORSLAER, E
    VACCINE, 1992, 10 : S88 - S92
  • [43] Methadone maintenance and HIV prevention: A cost-effectiveness analysis
    Zaric, GS
    Brandeau, ML
    Barnett, PG
    MANAGEMENT SCIENCE, 2000, 46 (08) : 1013 - 1031
  • [44] A Cost-Effectiveness Analysis of Population-Level Dental Caries Prevention Strategies in US Children
    Janusz, Cara B.
    Doan, Tran T.
    Gebremariam, Acham
    Rose, Angela
    Keels, Martha A.
    Quinonez, Rocio B.
    Eckert, George
    Yanca, Emily
    Fontana, Margherita
    Prosser, Lisa A.
    ACADEMIC PEDIATRICS, 2024, 24 (05) : 765 - 775
  • [45] Cost-effectiveness of renewable electricity policies
    Palmer, K
    Burtraw, D
    ENERGY ECONOMICS, 2005, 27 (06) : 873 - 894
  • [46] Cost-Effectiveness of Pneumococcal Vaccination Policies and Uptake Programs in US Older Populations
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (06) : 1271 - 1278
  • [47] Cost-effectiveness Analysis of Vascular Access Referral Policies in CKD
    Shechter, Steven M.
    Chandler, Talon
    Skandari, M. Reza
    Zalunardo, Nadia
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (03) : 368 - 376
  • [48] THE APPLICATION OF COST-EFFECTIVENESS ANALYSIS TO THE EVALUATION OF DRUG-ABUSE PREVENTION PROGRAMS - AN ILLUSTRATION
    HU, TW
    MCDONNELL, NS
    SWISHER, J
    JOURNAL OF DRUG ISSUES, 1981, 11 (01) : 125 - 138
  • [49] Cost-effectiveness of primary prevention of type 2 diabetes
    Icks, A.
    Chernyak, N.
    Klein, A.
    Brinks, R.
    Genz, J.
    Giani, G.
    DIABETOLOGE, 2011, 7 (02): : 92 - 98
  • [50] IMPLEMENTATION OF GUIDELINE-RECOMMENDED STRATEGIES FOR STROKE PREVENTION IN US ADULTS WITH TYPE 2 DIABETES: A COST-EFFECTIVENESS ANALYSIS
    Ye, W.
    Jiang, X.
    Kuo, S.
    Herman, W. H.
    Li, J.
    Morgenstern, L.
    Lisabeth, L. D.
    VALUE IN HEALTH, 2023, 26 (06) : S60 - S60